Regulatory Mechanisms Linking Spatial Gene Control and Genome Organization

连接空间基因控制和基因组组织的调控机制

基本信息

  • 批准号:
    10712390
  • 负责人:
  • 金额:
    $ 38.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Cellular homeostasis is maintained by signaling events that turn on downstream transcription factors to rapidly activate or repress hundreds of genes. The application of next-generation sequencing technologies and super- resolution imaging in the past decade has revealed the central role of non-coding regulatory elements called enhancers in the spatio-temporal control of mammalian gene expression. Recent evidence indicates that acute signaling events assemble the enhancer-bound transcriptional complex as membraneless compartments known as condensates. An important question is how these organelles interact with larger nuclear bodies to shape three-dimensional genome organization and spatial gene control. We have identified three critical challenges that limit our understanding of spatial gene control. Our research program is focused on solving these challenges to fill the critical knowledge gaps in signal-induced gene regulation. Challenge 1) Understand how enhancer communication works. In addition to controlling primary target genes, several pathway-specific enhancers engage in long-distance interactions. Our data indicate that enhancer hubs facilitate genome-wide coordination of signaling programs. The prevalence and regulatory features of this mechanism in signal-activated gene programs are just beginning to be explored. We will use prototypic type I and type II nuclear hormone receptors to study the role of enhancer hubs in transcription coordination. Challenge 2) Elucidate the interaction of non- coding genome and disordered proteome in gene control. We have reported that the ligand-induced enhancer condensates are composed of proteins with intrinsically disordered regions (IDR) and RNAs. Although a common feature of many transcriptional complexes, the molecular and enzymatic regulation of the assembly, dissolution, and material properties of transcriptional condensates are largely unknown. We will use single-cell CRISPR screening strategies, mutational scans, biophysical and genomics assays to identify enzymes controlling signaling-activated enhancers by modifying the IDR structure. Challenge 3) Unravel the cell biological basis of the spatial genome organization. The eukaryotic genome is compartmentalized based on the transcriptional states of the chromatin. Our data indicate that several nuclear architectural structures and transcriptional condensates act as solid-state anchors to facilitate long-distance enhancer interaction and organize chromatin architecture. To gain mechanistic insights into the role of common nuclear bodies in genome organization, we will employ genetic strategies to transiently degrade these organelles and assess the impact on three-dimensional chromatin structure and enhancer function using imaging and genomics tools. By addressing these questions at the intersection of non-coding genome, nuclear condensates, and gene regulation, we will unravel a cell biological basis of spatial gene control. This research will also contribute to developing innovative research tools to fill the knowledge gaps in the regulatory roles of the non-coding genome while facilitating the training and mentoring of the next generation of researchers in multidisciplinary science.
项目概要 细胞稳态是通过信号事件来维持的,这些信号事件会快速打开下游转录因子 激活或抑制数百个基因。新一代测序技术和超级测序技术的应用 过去十年的分辨率成像揭示了非编码调控元件的核心作用,称为 哺乳动物基因表达时空控制的增强子。最近的证据表明,急性 信号传导事件将增强子结合的转录复合物组装为已知的无膜区室 作为凝结物。一个重要的问题是这些细胞器如何与更大的核体相互作用以形成 三维基因组组织和空间基因控制。我们确定了三个关键挑战 这限制了我们对空间基因控制的理解。我们的研究计划致力于解决这些挑战 填补信号诱导基因调控方面的关键知识空白。挑战 1) 了解增强器如何 沟通工作。除了控制主要靶基因外,几种途径特异性增强子 进行远距离互动。我们的数据表明增强子中心促进全基因组协调 信号程序。信号激活基因中该机制的普遍性和调控特征 方案才刚刚开始探索。我们将使用原型 I 型和 II 型核激素受体 研究增强子中枢在转录协调中的作用。挑战 2)阐明非相互作用 基因控制中的编码基因组和无序蛋白质组。我们报道了配体诱导的 增强子凝聚物由具有本质无序区域 (IDR) 的蛋白质和 RNA 组成。虽然 许多转录复合物的共同特征,组装的分子和酶促调节, 转录缩合物的溶解和材料特性在很大程度上是未知的。我们将使用单细胞 用于识别酶的 CRISPR 筛选策略、突变扫描、生物物理和基因组学分析 通过修改 IDR 结构来控制信号传导激活的增强子。挑战 3) 解开细胞 空间基因组组织的生物学基础。真核生物基因组的划分基于 染色质的转录状态。我们的数据表明,一些核建筑结构和 转录缩合物充当固态锚以促进长距离增强子相互作用 组织染色质结构。获得基因组中常见核体作用的机制见解 组织,我们将采用遗传策略暂时降解这些细胞器并评估影响 使用成像和基因组学工具研究三维染色质结构和增强子功能。经过 在非编码基因组、核凝聚体和基因的交叉点上解决这些问题 调控,我们将揭示空间基因控制的细胞生物学基础。这项研究也将有助于 开发创新的研究工具来填补非编码基因组调控作用的知识空白 同时促进多学科科学研究下一代研究人员的培训和指导。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sreejith Janardhanan Nair其他文献

Sreejith Janardhanan Nair的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sreejith Janardhanan Nair', 18)}}的其他基金

Genomic strategies to identify novel gene regulatory mechanisms by ligand-activated transcriptional enhancers
通过配体激活转录增强子识别新基因调控机制的基因组策略
  • 批准号:
    10354014
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
Genomic strategies to identify novel gene regulatory mechanisms by ligand-activated transcriptional enhancers
通过配体激活转录增强子识别新基因调控机制的基因组策略
  • 批准号:
    10546446
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
Enhancer Codes with Ligand Mediated Gene Regulation and Chromatin Architecture
具有配体介导的基因调控和染色质结构的增强子代码
  • 批准号:
    9806301
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Enhancer Codes with Ligand Mediated Gene Regulation and Chromatin Architecture
具有配体介导的基因调控和染色质结构的增强子代码
  • 批准号:
    10194487
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Enhancer Codes with Ligand Mediated Gene Regulation and Chromatin Architecture
具有配体介导的基因调控和染色质结构的增强子代码
  • 批准号:
    10435941
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了